Paper Details

  1. Home
  2. Paper Details

Risperidone long-acting injection: safety and efficacy in elderly patients with schizophrenia.

Author: CatalánRosa, PenadésRafael

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Long-acting risperidone injections were found to be effective in treating the positive and negative symptoms of schizophrenia in elderly patients. Studies suggest that it has a safety profile similar to oral risperidone and patient acceptance is greater than with traditional oral medications.
Paper Details　
Original Abstract of the Article :
Antipsychotic medication is considered the cornerstone of the treatment in elderly patients with schizophrenia. Long acting risperidone injection was the first antipsychotic available for use in this group of patients. Current scientific literature revealed that long-acting risperidone is effective ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663602/

データ提供：米国国立医学図書館（NLM）

Risperidone Long-Acting Injection: A Promising Treatment for Elderly Schizophrenia Patients

Navigating the complexities of mental health, especially in the elderly, is like navigating a labyrinth. This study explores the safety and efficacy of risperidone long-acting injection, a potential treatment for schizophrenia in elderly patients. Schizophrenia, a complex mental health disorder, often requires long-term treatment, and the study aims to evaluate the effectiveness of risperidone long-acting injection in this specific population. The study highlights the potential benefits of this treatment in managing the positive and negative symptoms of schizophrenia, while also examining its safety profile.

Long-Term Management of Schizophrenia

The study suggests that long-acting risperidone is a viable option for the long-term management of schizophrenia in elderly patients. The researchers found that the treatment was effective in managing both the positive and negative symptoms of the disease. While further research is needed, the findings suggest that long-acting risperidone could significantly improve the quality of life for elderly patients with schizophrenia.

Navigating Mental Health Challenges

Schizophrenia is a complex condition that can impact individuals in various ways, much like the shifting sands of a desert. This research underscores the importance of ongoing research and development in mental health, specifically for the elderly. The study also highlights the need for further exploration of the effectiveness and long-term safety of long-acting risperidone compared to other antipsychotic medications.

Dr.Camel's Conclusion

This research provides valuable insights into the potential of risperidone long-acting injection as a treatment option for elderly patients with schizophrenia. The findings suggest that this treatment could effectively manage symptoms and improve the quality of life for those suffering from this complex disorder. Further research is essential to fully understand its long-term benefits and safety.

Date :
  1. Date Completed 2013-07-17
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

23861642

DOI: Digital Object Identifier

PMC3663602

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.